Pfizer - activities

Covid: Pfizer's Covid drug Paxlovid available in pharmacies from Friday

After being granted marketing approval from the European Medicines Agency, Pfizer's Covid drug Paxlovid - 89% effective against hospitalizations and deaths caused by coronavirus - will be available from Friday February 4, 2022, in pharmacies.

Covid: Pfizer’s Omicron vaccine to be ready in March

This Monday January 10, 2022, Pfizer announced their new version of the vaccine targeting the Omicron variant will be ready in March.

Omicron: immunity drops 10 weeks after the third dose, a UK study found

As the third dose vaccination campaign is going on in France, the UK health security agency has released a study showing immunity drops only ten weeks after the booster. Towards a fourth dose?

Covid: Pfizer to vaccinate children under 5 in 2022

After 5-11 years old, drugmaker Pfizer now wishes to vaccinate children under 5 years of age. They announced tests have already begun and they will seek approval by mid-2022.

Covid - Omicron variant: Pfizer vaccine 70% effective against severe disease, a study found

According toa South-African study carried out by the South African Medical Research Council, the Pfizer vaccine is 70% effective against the Covid Omicron variant, although it is still more resistant, according to a study carried out by the Africa Health Research Institute from Durban. Keep reading to find out more!

Omicron variant: current vaccines likely less effectives, according to Moderna CEO

Shall one fear a major loss in the effectiveness of the current vaccines because of the Omicron variant? Interview by the Financial Times, Moderna CEO Stéphane Bancel expects a “material drop” in the Covid vaccines effectiveness currently given.

Covid: third dose of Pfizer 95.6% effective against the virus, the laboratory claims

Pfizer-BioNTech has carried out a study showing their booster shot is 95.6% effective against symptomatic Covid-19.

Covid vaccines: new side effects under investigation

While the vaccination campaign is in full swing in France, as almost everywhere else on the Old Continent, the European Medicines Agency announced on Wednesday that it was investigating three rare infections, which could potentially be side effects of Pfizer and Moderna vaccines. No details were given as to the number of cases concerned.

Covid: No need “yet” to adapt the vaccine to new variants, Pfizer says

As the Delta variant urges some countries to make new health measures, this August 9, Pfizer/BioNTech laboratories head said there is no need “yet” to adapt the vaccine to new coronavirus variants.

Coronavirus vaccine in teenagers: Moderna vaccine allowed for 12-17 years old

In France, Moderna Covid vaccine is now approved by the Haute Autorité de Santé to be used in vaccinating teenagers aged 12 to 17. A decision following the prior approval released by the European Medicines Agency.

Vaccination: has France enough doses to meet the high demand of these past days?

Over two million appointments made in one week: Emmanuel Macron’s announcements made this past July 12 led to a large appointment demand in vaccination centers. But has France enough doses to immunize everyone?

Covid: Pfizer vaccine effective against the Indian variant, Institut Pasteur found

Good news in the race for Covid vaccines! According to several studies led in the United Kingdom, the Pfizer and AstraZeneca vaccines seem to be working against the Indian variant, at 88% for the former and 60% for the latter after the second injection. Results quite similar to those from the two vaccines against the UK variant. A study carried out by the Institut Pasteur issued this May 28 confirms Pfizer's effectiveness against the Indian variant.

Pfizer vaccine: does the second dose cause more side effects?

Headache, fever, shivers, fatigue… More and more French are complaining about disturbing side effects after they have been given the second dose of the Pfizer – BioNTech vaccine. According to doctors, there is nothing to be worried about.

Covid: Pfizer to develop two treatments against the virus

Two treatments against Covid are being studied, but have delivered encouraging primary results… This is what Pfizer France director David Lepoittevin announced this Friday April 9, stating that one of them was to be given orally, the other one intravenously. Two medicines that – if trials show effectiveness – could complete the existing arsenal amid the fight against coronavirus.

Covid vaccine: answers to questions you may have

As Covid vaccination is growing in France, many of you are wondering about the vaccines and how such an action is useful to curb the spread of the virus. Questions the editorial board tries to answer to.

Pfizer vaccine: booster shots likely to be needed, the laboratory warns

Because of Covid-19 variants and to guarantee longer immunity to people vaccinated with the Pfizer solution, the laboratory CEO warned that booster shots were likely to be needed by six to twelve months, then followed by one shot every year.

Covid: vaccine doses to be anonymized in France?

As more and more French distrust some Covid vaccines, Europe 1 radio station reports the Health Minister is considering anonymizing doses and therefore no longer tell the name of the vaccine given to the person during the appointment.

Covid: Pfizer vaccine less effective against the South African variant, a study finds

Pfizer covid vaccine is said to be less effective against the South African variant... This is at least what an Israeli study found on the matter, stating this strain is likely to "break through" the vaccine. The study shifts focus of the results from the previous study carried out by the American laboratory, explaining their vaccine was working for at least six months against all variants, and especially the South African strain.

Pfizer: France has launched the vaccine production in the country

According to news from our peers from Journal du Dimanche, the manufacturing of the Pfizer/BioNTech vaccine is to begin in France, at Delpharm, an expert in packing pharmaceutical product, starting Wednesday April 7. This is the very first Covid vaccine produced in France. In all 250 million doses are to be issued by the end of the year, according to Industry Minister Agnès Pannier-Runacher.

Covid vaccine: Pfizer to deliver 2 million fewer doses then expected in May

This hitch is said to slow France's vaccination campaign: American Pfizer laboratory has warned they will deliver 2 million fewer doses than expected in May.